推进心力衰竭护理:突破和新兴策略
Andrea Tedeschi1, Federico Barocelli2, Luigi Gerra1
1Cardiology Unit, Guglielmo da Saliceto Hospital, 29121 Piacenza, Italy.
Journal of clinical medicine
|October 29, 2025
概括
最近的心力衰竭治疗提供了新的希望,包括治疗糖尿病和肥胖的新药,以及治疗三腹的干预措施. 先进的治疗方法旨在克服器官短缺,将护理转向精准医学.
科学领域:
- 心脏病学 心脏病学
- 内部医学 内部医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 心力衰竭 (HF) 是一种复杂的综合征,尽管有进展,但死亡率很高.
- 治疗惯性和剂量不足限制了当前的高频管理.
- 了解高频连续性对于有效治疗至关重要.
研究的目的:
- 审查近期治疗心力衰竭的进展,跨越护理连续性.
- 突出高频管理的既定和新兴策略.
- 讨论解决先进高频器官缺陷的创新问题.
主要方法:
- 关于心力衰竭治疗的最新进展的文献综述.
- 专注于基于药物和设备的干预措施.
- 对高频管理新兴策略的分析.
主要成果:
- 早期启动基础HF疗法可以减少心血管事件,但面临实施挑战.
- 新型药物如芬瑞在心脏和脏方面有好处;GLP-1激动剂在HFpEF/HFmrEF方面有前途.
- 通过导管干预三管吐和器官捐献/人工心脏的创新解决了先进的HF.
结论:
- 在HF护理方面的进步包括精确指导疗法和多学科方法.
- 新的药理学药剂和干预措施正在扩大治疗选择.
- 解决实施中的挑战和器官短缺是未来高频率管理的关键.
相关概念视频
Heart Failure VI: Adjunct Therapies
246
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
246
Heart Failure V: Medical Management
209
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
209
Heart Failure IV: Classification and Diagnostic Evaluation
313
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
313
Cardiomyopathy V: Interprofessional Care
331
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
331
Heart Failure VII: Nursing Interventions
410
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
410
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
915
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
915


